Byrne Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.61M Sell
18,171
-353
-2% -$82.3K 2.49% 7
2026
Q1
$4.53M Sell
18,524
-405
-2% -$94.3K 2.65% 6
2025
Q4
$3.92M Sell
18,929
-32
-0.2% -$6.33K 2.16% 6
2025
Q3
$3.52M Sell
18,961
-60
-0.3% -$10.3K 2.16% 7
2025
Q2
$2.91M Hold
19,021
1.92% 8
2025
Q1
$3.15M Buy
19,021
+296
+2% +$46.3K 2.33% 6
2024
Q4
$2.71M Sell
18,725
-116
-0.6% -$18K 1.9% 10
2024
Q3
$3.05M Buy
18,841
+14
+0.1% +$2.23K 2.08% 7
2024
Q2
$2.74M Sell
18,827
-555
-3% -$82.5K 1.96% 7
2024
Q1
$3.07M Buy
19,382
+227
+1% +$36.1K 2.12% 5
2023
Q4
$2.99M Buy
19,155
+2,662
+16% +$408K 2.28% 5
2023
Q3
$2.57M Sell
16,493
-5,734
-26% -$946K 2.13% 7
2023
Q2
$3.68M Buy
22,227
+130
+0.6% +$21K 2.39% 5
2023
Q1
$3.42M Buy
22,097
+1,057
+5% +$171K 2.45% 5
2022
Q4
$3.72M Sell
21,040
-63
-0.3% -$10.9K 2.69% 3
2022
Q3
$3.45M Sell
21,103
-75
-0.4% -$12.7K 2.66% 7
2022
Q2
$3.76M Buy
21,178
+92
+0.4% +$16.4K 2.78% 7
2022
Q1
$3.74M Sell
21,086
-200
-0.9% -$34K 2.33% 6
2021
Q4
$3.64M Buy
+21,286
New +$3.48M 2.36% 6

Other funds holding JNJ

Byrne Asset Management's JNJ Position: Q2 2026 in Review

Byrne Asset Management reduced its Johnson & Johnson (JNJ) stake by 1.9% in Q2 2026, selling an estimated $82.3K and leaving 18,171 shares worth $4.61M. The position accounts for 2.49% of the portfolio, ranked #7.

Byrne Asset Management first reported a position in JNJ in Q4 2021 and has held it in 19 quarters since. 899 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Byrne Asset Management held 18,171 shares of Johnson & Johnson worth $4.61M as of Q2 2026.
  • Byrne Asset Management sold 353 Johnson & Johnson shares in Q2 2026, an estimated $82.3K.
  • Johnson & Johnson made up 2.49% of Byrne Asset Management's portfolio in Q2 2026, its #7 holding.
  • Byrne Asset Management first reported a position in Johnson & Johnson in Q4 2021 and has held it in 19 quarters since.
  • 899 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Byrne Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.